GB929206412A
GB9206412D0
(en)
|
1992-03-24 |
1992-03-24 |
Pharmaceutical compositions
|
AU19860/92A
AU672361B2
(en)
|
1991-06-24 |
1992-06-18 |
Use of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione in the treatment of tyrosinaemia and pharmaceutical compositions
|
DE1992628813
DE122005000032I2
(en)
|
1991-06-24 |
1992-06-18 |
Use of 2- (2-nitro-4-trifluoromethylbenzoyl) -1,3-cyclohexanedione for the treatment of tyrosine and pharmaceutical compositions
|
DK92912215T
DK0591275T3
(en)
|
1991-06-24 |
1992-06-18 |
Use of 2- (2-nitro-4-trifluoromethylbenzoyl) -1,3-cyclohexanedione for the treatment of tyrosine anemia and pharmaceuticals together
|
PCT/GB1992/001094
WO1993000080A1
(en)
|
1991-06-24 |
1992-06-18 |
Use of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione in the treatment of tyrosinaemia and pharmaceutical compositions
|
ES92912215T
ES2129448T3
(en)
|
1991-06-24 |
1992-06-18 |
USE OF 2- (2-NITRO-4-TRIFLUOROMETILBENZOIL) -1,3-CYCLLOHEXANODIONA IN THE TREATMENT OF THYROSINEMIA AND PHARMACEUTICAL COMPOSITIONS.
|
AT92912215T
ATE178207T1
(en)
|
1991-06-24 |
1992-06-18 |
USE OF 2-(2-NITRO-4-TRIFLUORMETHYLBENZOYL)-1,3-CYCLOHEXANDIONE FOR THE TREATMENT OF TYROSINEMIA AND PHARMACEUTICAL COMPOSITIONS
|
EP92912215A
EP0591275B1
(en)
|
1991-06-24 |
1992-06-18 |
Use of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione in the treatment of tyrosinaemia and pharmaceutical compositions
|
DE69228813T
DE69228813T2
(en)
|
1991-06-24 |
1992-06-18 |
USE OF 2- (2-NITRO-4-TRIFLUORMETHYLBENZOYL) -1,3-CYCLOHEXANDION FOR THE TREATMENT OF TYROSINEMIA AND PHARMACEUTICAL COMPOSITIONS
|
JP05501383A
JP3130935B2
(en)
|
1991-06-24 |
1992-06-18 |
Pharmaceutical composition
|
CA002072047A
CA2072047C
(en)
|
1991-06-24 |
1992-06-23 |
Pharmaceutical compositions
|
PT100619A
PT100619B
(en)
|
1991-06-24 |
1992-06-24 |
PHARMACEUTICAL COMPOSITIONS
|
IE202492A
IE922024A1
(en)
|
1991-06-24 |
1992-07-01 |
Pharmaceutical compositions
|
NO934798A
NO304923B1
(en)
|
1991-06-24 |
1993-12-23 |
Pharmaceutical preparation containing 2- (2-nitro-4-trifluoromethylbenzoyl) -1,3-cyclohexanedione or a pharmaceutically acceptable salt thereof
|
US08/359,361
US5550165A
(en)
|
1991-06-24 |
1994-12-19 |
Pharmaceutical compositions for the treatment of hereditary tyosinemia type I
|
HK98109412A
HK1008662A1
(en)
|
1991-06-24 |
1998-07-27 |
Use of 2-(2-nitro-4- trifluoromethylbenzoyl)-1,3 yclohexanedione in the treatment of tyrosinaemia and pharmaceutical compositions
|
GR990400803T
GR3029841T3
(en)
|
1991-06-24 |
1999-04-01 |
Method of preparing a radioactive rhenium complex solution.
|
NL300198C
NL300198I2
(en)
|
1991-06-24 |
2005-06-09 |
Use of 2- (2-nitro-4-trifluoromethylbenzoyl) cyclohexanedione-1,3 for the treatment of tyrosinaemia, as well as pharmaceutical preparations.
|
LU91180C
LU91180I2
(en)
|
1991-06-24 |
2005-07-06 |
2- (2-Nirto-4trifluoromethylbenzoyl) -1,3-cyclohexanedione or one of its salts (in abbreviation "NTBC", common name nitisinone, brand name orfadin.
|
NO2005018C
NO2005018I2
(en)
|
1991-06-24 |
2005-08-31 |
2- (2-Nitro-4-trifluoromethylbenzoyl) 1,3-cyclohexanedione or a salt thereof (Abbreviation: NTBC)
|
NO2017045C
NO2017045I1
(en)
|
1991-06-24 |
2017-08-23 |
A pharmaceutical composition containing 2- (2-nitro-4-ifluoromethylbenzoyl) -1,3-cyclohexanedione or a pharmaceutically acceptable salt thereof
|